These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 29060930)
1. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer. Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930 [TBL] [Abstract][Full Text] [Related]
2. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer. An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer. Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772 [TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer. Meng Q; Xiang L; Fu J; Chu X; Wang C; Yan B Oncotarget; 2017 Jun; 8(23):37321-37331. PubMed ID: 28418879 [TBL] [Abstract][Full Text] [Related]
5. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis. Li M; Li BY; Xia H; Jiang LL Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of candidate microRNAs in gastric cancer: A validation study. Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528 [TBL] [Abstract][Full Text] [Related]
7. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5. Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189 [TBL] [Abstract][Full Text] [Related]
8. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517 [TBL] [Abstract][Full Text] [Related]
10. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer. Qu M; Li L; Zheng WC Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3384-3388. PubMed ID: 28829504 [TBL] [Abstract][Full Text] [Related]
11. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730 [TBL] [Abstract][Full Text] [Related]
13. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer. Meng FM; Meng FM; Song XL Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199 [TBL] [Abstract][Full Text] [Related]
14. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439 [TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of miR-141 downregulation in gastric cancer. Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225 [TBL] [Abstract][Full Text] [Related]
17. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway. Zeng B; Shi W; Tan G BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764 [TBL] [Abstract][Full Text] [Related]
18. microRNA analysis of gastric cancer patients from Saudi Arabian population. Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962 [TBL] [Abstract][Full Text] [Related]
19. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. Su Z; Zhao J; Rong Z; Geng W; Wang Z Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer. Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]